US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Allarity Therapeutics Inc

0.8307

+0.02072.56%

Post-market: 0.83880.0081+0.98%19:38 EST

Volume:171.27K

Turnover:141.45K

Market Cap:13.13M

PE:-0.62

High:0.8550

Open:0.8200

Low:0.8010

Close:0.8100

52wk High:2.35

52wk Low:0.6138

Shares:15.81M

Float Shares:15.79M

Volume Ratio:0.48

T/O Rate:1.08%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.3348

EPS(LYR):-15.6529

ROE:-122.61%

ROA:-51.62%

PB:1.09

PE(LYR):-0.05

Loading ...

Overview Company News Filings

Allarity announce enrollment open for Phase 2 trial of stenoparib, temozolomide

Allarity Therapeutics Announces That Its Collaborative Phase 2 Trial With the United States Veteran’s Administration Combining Stenoparib With Temozolomide in Relapsed Small Cell Lung Cancer Is NOW Open for Enrollment

THOMSON REUTERS

Allarity Therapeutics Partners with U.S. Department of Veterans Affairs for Phase 2 Cancer Trial

Allarity Therapeutics Inc - on Jan 28, Co Entered Stock Purchase Agreement With Tumim Stone Capital - SEC Filing

THOMSON REUTERS

Allarity Therapeutics Inc - Company May Sell up to $6 Mln in Newly Issued Shares - SEC Filing

THOMSON REUTERS

Allarity Therapeutics Advances Stenoparib Toward FDA Approval After Strategic Realignment

Allarity Therapeutics Raises $2.5 Million in Private Placement of Unregistered Shares

Allarity Therapeutics Sets New CFO Compensation Package With $367,700 Salary and $160,000 RSUs

BRIEF-Allarity Therapeutics Inc - To Offer Up To $50 Million In Securities

Allarity Therapeutics Inc - to Offer up to $50 Mln in Securities - SEC Filing

THOMSON REUTERS

Allarity Therapeutics's Q3 net loss narrows

Allarity Therapeutics reports third quarter net loss of $2.8 million

Allarity Therapeutics Q3 Operating Expenses USD 2.518 Million

THOMSON REUTERS

Allarity Therapeutics Provides Third Quarter 2025 Financial Results and Provides Business Updates

THOMSON REUTERS

U.S. RESEARCH ROUNDUP-Carmax, Mirion Technologies, Valmont Industries

Allarity Therapeutics Inc : Ascendiant Capital Markets Raises Target Price to $9.25 From $9

THOMSON REUTERS

Allarity files to sell 1.56M shares of common stock for holders

Allarity Therapeutics Announces Landmark Phase 2 Results: Stenoparib Surpasses 25-Month Median Overall Survival in Advanced Ovarian Cancer Trial

Allarity Therapeutics CEO to Present at Biomarkers & Precision Medicine 2025 Conference

Allarity presents new Phase 2 clinical data for Stenoparib

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ALLR/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALLR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALLR\",,,,,undefined,":{"symbol":"ALLR","market":"US","secType":"STK","nameCN":"Allarity Therapeutics Inc","latestPrice":0.8307,"timestamp":1770411600000,"preClose":0.81,"halted":0,"volume":171265,"hourTrading":{"tag":"盘后","latestPrice":0.8388,"preClose":0.8307,"latestTime":"19:38 EST","volume":9559,"amount":7992.334339,"timestamp":1770424700401,"change":0.0081,"changeRate":0.009751,"amplitude":0.051282},"delay":0,"changeRate":0.02555555555555548,"floatShares":15787000,"shares":15811900,"eps":-1.334837,"marketStatus":"Market Closed","change":0.0207,"latestTime":"02-06 16:00:00 EST","open":0.82,"high":0.855,"low":0.801,"amount":141451.82933110002,"amplitude":0.066667,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.334837,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.81,"preHourTrading":{"tag":"盘前","latestPrice":0.86,"preClose":0.81,"latestTime":"08:12 EST","volume":130,"amount":109.0499995,"timestamp":1770383556014,"change":0.05,"changeRate":0.061728,"amplitude":0.061728},"postHourTrading":{"tag":"盘后","latestPrice":0.8388,"preClose":0.8307,"latestTime":"19:38 EST","volume":9559,"amount":7992.334339,"timestamp":1770424700401,"change":0.0081,"changeRate":0.009751,"amplitude":0.051282},"volumeRatio":0.4786767820624687},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALLR\",,,,,undefined,":{"symbol":"ALLR","floatShares":15787000,"roa":"-51.62%","roe":"-122.61%","lyrEps":-15.652876,"volumeRatio":0.4786767820624687,"shares":15811900,"dividePrice":0,"high":0.855,"amplitude":0.066667,"preClose":0.81,"low":0.801,"week52Low":0.6138,"pbRate":"1.09","psRate":"-12.52","week52High":2.35,"institutionHeld":0,"latestPrice":0.8307,"eps":-1.334837,"divideRate":0,"volume":171265,"delay":0,"ttmEps":-1.334837,"open":0.82,"prevYearClose":1.08,"prevWeekClose":1,"prevMonthClose":1,"prevQuarterClose":1.08,"fiveDayClose":1,"twentyDayClose":1.19,"sixtyDayClose":1.22},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALLR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-14","symbol":"ALLR","fiscalQuarterEnding":"2025/09","expectedEps":-0.23,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"pre","actualEps":-0.19},{"market":"US","date":"2024-09-11","symbol":"ALLR","defaultRemindTime":1726061400000,"type":"split","dateTimestamp":1726027200000,"forFactor":30,"toFactor":1,"ratio":30},{"market":"US","date":"2024-04-09","symbol":"ALLR","defaultRemindTime":1712669400000,"type":"split","dateTimestamp":1712635200000,"forFactor":20,"toFactor":1,"ratio":20},{"market":"US","date":"2023-06-29","symbol":"ALLR","defaultRemindTime":1688045400000,"type":"split","dateTimestamp":1688011200000,"forFactor":40,"toFactor":1,"ratio":40},{"market":"US","date":"2023-03-27","symbol":"ALLR","defaultRemindTime":1679923800000,"type":"split","dateTimestamp":1679889600000,"forFactor":1000000,"toFactor":28571,"ratio":35.00052500787512}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALLR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALLR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1753678800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ALLR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ALLR","date":"2026-02-05","current":-0.622323,"percent":0.316253,"low":-15.065068,"twenty":-2.809596,"median":-0.509023,"eighty":-0.182989,"high":-0.014442,"avg":-1.58237,"sd":2.472244,"marketCap":13546617},"quantilePoints":[{"date":"2021-02-12","current":-1.104854,"twenty":-9.702533,"median":-5.386942,"eighty":-1.568654,"marketCap":18292862},{"date":"2021-02-19","current":-1.104562,"twenty":-9.698527,"median":-5.382435,"eighty":-1.539318,"marketCap":18312151},{"date":"2021-02-26","current":-1.488638,"twenty":-9.697576,"median":-5.37795,"eighty":-1.521178,"marketCap":24593543},{"date":"2021-03-05","current":-3.669148,"twenty":-9.696076,"median":-5.365464,"eighty":-1.52432,"marketCap":24223718},{"date":"2021-03-12","current":-3.929976,"twenty":-9.678686,"median":-5.329871,"eighty":-1.530059,"marketCap":25945701},{"date":"2021-03-19","current":-3.631791,"twenty":-9.653118,"median":-5.278549,"eighty":-1.539318,"marketCap":23977082},{"date":"2021-03-26","current":-3.488661,"twenty":-9.640665,"median":-5.184491,"eighty":-1.543911,"marketCap":23032143},{"date":"2021-04-01","current":-3.327696,"twenty":-9.629028,"median":-4.951435,"eighty":-1.552673,"marketCap":21969450},{"date":"2021-04-09","current":-3.757094,"twenty":-9.614281,"median":-4.633335,"eighty":-1.567201,"marketCap":24804334},{"date":"2021-04-16","current":-3.486692,"twenty":-9.613138,"median":-4.517475,"eighty":-1.570864,"marketCap":23019141},{"date":"2021-04-23","current":-3.493291,"twenty":-9.609584,"median":-4.473291,"eighty":-1.57449,"marketCap":23062706},{"date":"2021-04-30","current":-3.543201,"twenty":-9.606597,"median":-4.261186,"eighty":-1.578902,"marketCap":23392213},{"date":"2021-05-07","current":-3.374584,"twenty":-9.606011,"median":-4.102485,"eighty":-1.584896,"marketCap":22279006},{"date":"2021-05-14","current":-3.43495,"twenty":-9.605096,"median":-4.064383,"eighty":-1.588716,"marketCap":22677540},{"date":"2021-05-21","current":-4.930204,"twenty":-9.604309,"median":-3.974599,"eighty":-1.5889,"marketCap":32549204},{"date":"2021-05-28","current":-3.769439,"twenty":-9.603377,"median":-3.960146,"eighty":-1.589809,"marketCap":27342818},{"date":"2021-06-04","current":-3.576722,"twenty":-9.601959,"median":-3.934026,"eighty":-1.593299,"marketCap":25944888},{"date":"2021-06-11","current":-5.465881,"twenty":-9.598634,"median":-3.929976,"eighty":-1.603054,"marketCap":39648497},{"date":"2021-06-18","current":-5.338355,"twenty":-9.595624,"median":-3.960146,"eighty":-1.604095,"marketCap":38723448},{"date":"2021-06-25","current":-5.511935,"twenty":-9.595014,"median":-4.044785,"eighty":-1.608386,"marketCap":39982566},{"date":"2021-07-02","current":-5.744917,"twenty":-9.592518,"median":-4.094839,"eighty":-1.609154,"marketCap":41672579},{"date":"2021-07-09","current":-5.404135,"twenty":-9.592255,"median":-4.132551,"eighty":-1.609278,"marketCap":39200603},{"date":"2021-07-16","current":-5.098506,"twenty":-9.58949,"median":-4.370958,"eighty":-1.616556,"marketCap":36983630},{"date":"2021-07-23","current":-5.35292,"twenty":-9.579569,"median":-4.482422,"eighty":-1.626496,"marketCap":38829101},{"date":"2021-07-30","current":-6.483419,"twenty":-9.574652,"median":-4.535987,"eighty":-1.639576,"marketCap":47029533},{"date":"2021-08-06","current":-11.008474,"twenty":-9.58949,"median":-4.729464,"eighty":-1.641298,"marketCap":79853455},{"date":"2021-08-13","current":-12.327699,"twenty":-9.595624,"median":-4.930204,"eighty":-1.647094,"marketCap":89422873},{"date":"2021-08-20","current":-13.923707,"twenty":-9.604587,"median":-5.087371,"eighty":-1.650841,"marketCap":101000021},{"date":"2021-08-27","current":-6.791388,"twenty":-9.603893,"median":-5.154974,"eighty":-1.653044,"marketCap":82060818},{"date":"2021-09-03","current":-6.07801,"twenty":-9.602602,"median":-5.173043,"eighty":-1.665466,"marketCap":73441020},{"date":"2021-09-10","current":-6.328485,"twenty":-9.600029,"median":-5.192908,"eighty":-1.668865,"marketCap":76467525},{"date":"2021-09-17","current":-6.330748,"twenty":-9.596376,"median":-5.219054,"eighty":-1.674426,"marketCap":76494873},{"date":"2021-09-24","current":-6.360661,"twenty":-9.595622,"median":-5.232201,"eighty":-1.682983,"marketCap":76856318},{"date":"2021-10-01","current":-6.386807,"twenty":-9.593192,"median":-5.278549,"eighty":-1.691188,"marketCap":77172241},{"date":"2021-10-08","current":-5.466428,"twenty":-9.592321,"median":-5.319527,"eighty":-1.693872,"marketCap":66051235},{"date":"2021-10-15","current":-6.438787,"twenty":-9.590043,"median":-5.33272,"eighty":-1.697688,"marketCap":77800308},{"date":"2021-10-22","current":-6.310214,"twenty":-9.581553,"median":-5.351199,"eighty":-1.69883,"marketCap":76246761},{"date":"2021-10-29","current":-5.738264,"twenty":-9.575635,"median":-5.365464,"eighty":-1.699342,"marketCap":69335845},{"date":"2021-11-05","current":-5.791162,"twenty":-9.571951,"median":-5.37795,"eighty":-1.704764,"marketCap":69975014},{"date":"2021-11-12","current":-9.137796,"twenty":-9.570869,"median":-5.379637,"eighty":-1.710665,"marketCap":110412625},{"date":"2021-11-19","current":-10.677125,"twenty":-9.590043,"median":-5.382551,"eighty":-1.7155,"marketCap":129012451},{"date":"2021-11-26","current":-8.087893,"twenty":-9.590596,"median":-5.387337,"eighty":-1.719697,"marketCap":98430113},{"date":"2021-12-03","current":-9.822616,"twenty":-9.595623,"median":-5.391453,"eighty":-1.722648,"marketCap":119541791},{"date":"2021-12-10","current":-8.786506,"twenty":-9.593799,"median":-5.399678,"eighty":-1.72374,"marketCap":106932281},{"date":"2021-12-17","current":-7.701563,"twenty":-9.592387,"median":-5.404135,"eighty":-1.724185,"marketCap":93728457},{"date":"2021-12-23","current":-7.94577,"twenty":-9.591149,"median":-5.406916,"eighty":-1.724491,"marketCap":96700473},{"date":"2021-12-31","current":-6.884308,"twenty":-9.585522,"median":-5.424256,"eighty":-1.724937,"marketCap":83782418},{"date":"2022-01-07","current":-7.133482,"twenty":-9.577602,"median":-5.43559,"eighty":-1.725736,"marketCap":86814883},{"date":"2022-01-14","current":-5.965582,"twenty":-9.573302,"median":-5.468362,"eighty":-1.729325,"marketCap":72601469},{"date":"2022-01-21","current":-5.28873,"twenty":-9.571174,"median":-5.463571,"eighty":-1.733928,"marketCap":64364150},{"date":"2022-01-28","current":-5.175922,"twenty":-9.570656,"median":-5.434718,"eighty":-1.739686,"marketCap":62991263},{"date":"2022-02-04","current":-5.90586,"twenty":-9.569676,"median":-5.448426,"eighty":-1.751548,"marketCap":71874647},{"date":"2022-02-11","current":-5.24228,"twenty":-9.567087,"median":-5.434718,"eighty":-1.762209,"marketCap":63798844},{"date":"2022-02-18","current":-4.37299,"twenty":-9.565157,"median":-5.427048,"eighty":-1.762699,"marketCap":53219542},{"date":"2022-02-25","current":-2.820214,"twenty":-9.564611,"median":-5.414601,"eighty":-1.763909,"marketCap":34322162},{"date":"2022-03-04","current":-1.977468,"twenty":-9.559507,"median":-5.406916,"eighty":-1.768226,"marketCap":24065893},{"date":"2022-03-11","current":-1.546141,"twenty":-9.556841,"median":-5.403258,"eighty":-1.762396,"marketCap":18816621},{"date":"2022-03-18","current":-1.280709,"twenty":-9.553747,"median":-5.396976,"eighty":-1.733064,"marketCap":15586299},{"date":"2022-03-25","current":-1.413425,"twenty":-9.553745,"median":-5.391266,"eighty":-1.724225,"marketCap":17201460},{"date":"2022-04-01","current":-1.37361,"twenty":-9.548351,"median":-5.386942,"eighty":-1.716423,"marketCap":16716912},{"date":"2022-04-08","current":-1.260801,"twenty":-9.547579,"median":-5.382386,"eighty":-1.698894,"marketCap":15344025},{"date":"2022-04-14","current":-1.313888,"twenty":-9.545703,"median":-5.378988,"eighty":-1.691188,"marketCap":15990090},{"date":"2022-04-22","current":-1.340431,"twenty":-9.545147,"median":-5.377643,"eighty":-1.662982,"marketCap":16313122},{"date":"2022-04-29","current":-1.028549,"twenty":-9.544583,"median":-5.37023,"eighty":-1.644802,"marketCap":12517494},{"date":"2022-05-06","current":-0.942283,"twenty":-9.542682,"median":-5.35292,"eighty":-1.6151,"marketCap":11467640},{"date":"2022-05-13","current":-0.816203,"twenty":-9.540711,"median":-5.335538,"eighty":-1.605357,"marketCap":9933237},{"date":"2022-05-20","current":-0.680226,"twenty":-9.538966,"median":-5.320857,"eighty":-1.59051,"marketCap":18126650},{"date":"2022-05-27","current":-0.952495,"twenty":-9.537854,"median":-5.291794,"eighty":-1.581759,"marketCap":25377311},{"date":"2022-06-03","current":-0.99232,"twenty":-9.53458,"median":-5.277138,"eighty":-1.571605,"marketCap":26438383},{"date":"2022-06-10","current":-0.703832,"twenty":-9.532045,"median":-5.235798,"eighty":-1.543911,"marketCap":18752203},{"date":"2022-06-17","current":-0.599303,"twenty":-9.530808,"median":-5.222317,"eighty":-1.52432,"marketCap":15967223},{"date":"2022-06-24","current":-0.623693,"twenty":-9.527156,"median":-5.196623,"eighty":-1.514058,"marketCap":16617051},{"date":"2022-07-01","current":-0.452961,"twenty":-9.522379,"median":-5.176862,"eighty":-1.499106,"marketCap":12068249},{"date":"2022-07-08","current":-0.470383,"twenty":-9.521562,"median":-5.169224,"eighty":-1.486494,"marketCap":12532413},{"date":"2022-07-15","current":-0.41115,"twenty":-9.518691,"median":-5.155494,"eighty":-1.469076,"marketCap":10954257},{"date":"2022-07-22","current":-0.386759,"twenty":-9.512769,"median":-5.113049,"eighty":-1.459875,"marketCap":10304428},{"date":"2022-07-29","current":-0.418118,"twenty":-9.50347,"median":-5.02298,"eighty":-1.436457,"marketCap":11139923},{"date":"2022-08-05","current":-0.437957,"twenty":-9.503061,"median":-4.91049,"eighty":-1.431164,"marketCap":11668493},{"date":"2022-08-12","current":-0.429214,"twenty":-9.500102,"median":-4.826114,"eighty":-1.420566,"marketCap":11435559},{"date":"2022-08-19","current":-0.507593,"twenty":-9.489287,"median":-4.757867,"eighty":-1.410827,"marketCap":13523792},{"date":"2022-08-26","current":-0.517011,"twenty":-9.484566,"median":-4.588542,"eighty":-1.402824,"marketCap":13623231},{"date":"2022-09-02","current":-0.403797,"twenty":-9.483144,"median":-4.498963,"eighty":-1.399007,"marketCap":10640042},{"date":"2022-09-09","current":-0.441535,"twenty":-9.481789,"median":-4.473291,"eighty":-1.386882,"marketCap":11634438},{"date":"2022-09-16","current":-0.471725,"twenty":-9.478583,"median":-4.416224,"eighty":-1.377196,"marketCap":12429955},{"date":"2022-09-23","current":-0.443893,"twenty":-9.477181,"median":-4.370958,"eighty":-1.353703,"marketCap":11696576},{"date":"2022-09-30","current":-0.428318,"twenty":-9.475416,"median":-4.165983,"eighty":-1.344911,"marketCap":11286170},{"date":"2022-10-07","current":-0.404955,"twenty":-9.469364,"median":-4.102485,"eighty":-1.335422,"marketCap":10670561},{"date":"2022-10-14","current":-0.321238,"twenty":-9.463127,"median":-4.064383,"eighty":-1.327159,"marketCap":8464627},{"date":"2022-10-21","current":-0.288141,"twenty":-9.454642,"median":-3.974599,"eighty":-1.313742,"marketCap":7592514},{"date":"2022-10-28","current":-0.22584,"twenty":-9.438712,"median":-3.934026,"eighty":-1.298879,"marketCap":5950889},{"date":"2022-11-04","current":-0.22584,"twenty":-9.428182,"median":-3.909562,"eighty":-1.29166,"marketCap":5950889},{"date":"2022-11-11","current":-0.218053,"twenty":-9.423542,"median":-3.767008,"eighty":-1.280709,"marketCap":5745686},{"date":"2022-11-18","current":-0.143465,"twenty":-9.416219,"median":-3.750498,"eighty":-1.268502,"marketCap":4309265},{"date":"2022-11-25","current":-0.150297,"twenty":-9.415689,"median":-3.750033,"eighty":-1.262596,"marketCap":4514468},{"date":"2022-12-02","current":-0.170792,"twenty":-9.411764,"median":-3.737805,"eighty":-1.25836,"marketCap":5130077},{"date":"2022-12-09","current":-0.128094,"twenty":-9.390014,"median":-3.714705,"eighty":-1.247239,"marketCap":3847558},{"date":"2022-12-16","current":-0.121655,"twenty":-9.374615,"median":-3.674148,"eighty":-1.240651,"marketCap":3654164},{"date":"2022-12-23","current":-0.106638,"twenty":-9.36966,"median":-3.663488,"eighty":-1.232735,"marketCap":3203092},{"date":"2022-12-30","current":-0.141128,"twenty":-9.358016,"median":-3.645501,"eighty":-1.226192,"marketCap":4239047},{"date":"2023-01-06","current":-0.112402,"twenty":-9.358016,"median":-3.620802,"eighty":-1.220151,"marketCap":3376232},{"date":"2023-01-13","current":-0.117206,"twenty":-9.358016,"median":-3.576722,"eighty":-1.209043,"marketCap":3520515},{"date":"2023-01-20","current":-0.1552,"twenty":-9.358016,"median":-3.543201,"eighty":-1.20518,"marketCap":4661731},{"date":"2023-01-27","current":-0.148595,"twenty":-9.358016,"median":-3.526345,"eighty":-1.193797,"marketCap":4463360},{"date":"2023-02-03","current":-0.144988,"twenty":-9.358016,"median":-3.497241,"eighty":-1.170794,"marketCap":4354990},{"date":"2023-02-10","current":-0.11484,"twenty":-9.358016,"median":-3.486692,"eighty":-1.156736,"marketCap":3449460},{"date":"2023-02-17","current":-0.112027,"twenty":-9.358016,"median":-3.443135,"eighty":-1.143172,"marketCap":3364969},{"date":"2023-02-24","current":-0.12065,"twenty":-9.358016,"median":-3.382903,"eighty":-1.137879,"marketCap":3623954},{"date":"2023-03-03","current":-0.121078,"twenty":-9.358016,"median":-3.358196,"eighty":-1.108482,"marketCap":3636811},{"date":"2023-03-10","current":-0.162799,"twenty":-9.358016,"median":-3.334518,"eighty":-1.093655,"marketCap":4889999},{"date":"2023-03-17","current":-0.196164,"twenty":-9.358016,"median":-3.27798,"eighty":-1.079982,"marketCap":3149999},{"date":"2023-03-24","current":-0.164233,"twenty":-9.358016,"median":-3.109636,"eighty":-1.059903,"marketCap":2637252},{"date":"2023-03-31","current":-0.102512,"twenty":-9.354336,"median":-3.004245,"eighty":-1.029973,"marketCap":1646137},{"date":"2023-04-06","current":-0.082986,"twenty":-9.354336,"median":-2.929285,"eighty":-1.012446,"marketCap":1332587},{"date":"2023-04-14","current":-0.066511,"twenty":-9.358016,"median":-2.820214,"eighty":-0.99415,"marketCap":1068029},{"date":"2023-04-21","current":-0.14435,"twenty":-9.358016,"median":-2.733948,"eighty":-0.958979,"marketCap":2317972},{"date":"2023-04-28","current":-0.114699,"twenty":-9.358016,"median":-2.579161,"eighty":-0.922616,"marketCap":1841829},{"date":"2023-05-05","current":-0.104296,"twenty":-9.358016,"median":-2.521603,"eighty":-0.872292,"marketCap":1674779},{"date":"2023-05-12","current":-0.101874,"twenty":-9.358016,"median":-2.462507,"eighty":-0.834292,"marketCap":1635898},{"date":"2023-05-19","current":-0.369853,"twenty":-9.358016,"median":-2.376461,"eighty":-0.828577,"marketCap":6039702},{"date":"2023-05-26","current":-0.400801,"twenty":-9.358016,"median":-2.320715,"eighty":-0.785743,"marketCap":6545085},{"date":"2023-06-02","current":-0.300337,"twenty":-9.34351,"median":-2.196258,"eighty":-0.723477,"marketCap":4904506},{"date":"2023-06-09","current":-0.21394,"twenty":-9.122722,"median":-2.175857,"eighty":-0.638327,"marketCap":3493647},{"date":"2023-06-16","current":-0.224022,"twenty":-8.823664,"median":-2.145226,"eighty":-0.61533,"marketCap":3658279},{"date":"2023-06-23","current":-0.212534,"twenty":-8.527273,"median":-2.128603,"eighty":-0.582498,"marketCap":3470675},{"date":"2023-06-30","current":-0.225725,"twenty":-8.379964,"median":-2.122568,"eighty":-0.546842,"marketCap":3686095},{"date":"2023-07-07","current":-0.687809,"twenty":-8.21667,"median":-2.104725,"eighty":-0.507967,"marketCap":11231921},{"date":"2023-07-14","current":-0.64364,"twenty":-8.007542,"median":-2.076142,"eighty":-0.507967,"marketCap":10510644},{"date":"2023-07-21","current":-0.591015,"twenty":-7.856275,"median":-2.056456,"eighty":-0.507967,"marketCap":9651283},{"date":"2023-07-28","current":-0.544463,"twenty":-7.700974,"median":-2.023929,"eighty":-0.507967,"marketCap":8891079},{"date":"2023-08-04","current":-0.47767,"twenty":-7.529826,"median":-2.011853,"eighty":-0.502328,"marketCap":7800352},{"date":"2023-08-11","current":-0.420997,"twenty":-7.327538,"median":-1.977468,"eighty":-0.475499,"marketCap":6874886},{"date":"2023-08-18","current":-0.4178,"twenty":-7.20066,"median":-1.950092,"eighty":-0.471193,"marketCap":5685002},{"date":"2023-08-25","current":-0.354966,"twenty":-7.143129,"median":-1.9278,"eighty":-0.460884,"marketCap":4830016},{"date":"2023-09-01","current":-0.371009,"twenty":-7.089352,"median":-1.914364,"eighty":-0.454191,"marketCap":5048322},{"date":"2023-09-08","current":-0.280764,"twenty":-7.062377,"median":-1.892638,"eighty":-0.448026,"marketCap":3820352},{"date":"2023-09-15","current":-0.200546,"twenty":-6.992598,"median":-1.864735,"eighty":-0.442785,"marketCap":2728823},{"date":"2023-09-22","current":-0.150409,"twenty":-6.943549,"median":-1.843492,"eighty":-0.439729,"marketCap":2046617},{"date":"2023-09-29","current":-0.154621,"twenty":-6.84092,"median":-1.827425,"eighty":-0.437769,"marketCap":2103922},{"date":"2023-10-06","current":-0.130956,"twenty":-6.736522,"median":-1.812798,"eighty":-0.429782,"marketCap":1781921},{"date":"2023-10-13","current":-0.143992,"twenty":-6.611201,"median":-1.794008,"eighty":-0.428318,"marketCap":1959294},{"date":"2023-10-20","current":-0.215326,"twenty":-6.56294,"median":-1.783004,"eighty":-0.423572,"marketCap":2929936},{"date":"2023-10-27","current":-0.183334,"twenty":-6.498137,"median":-1.780615,"eighty":-0.422453,"marketCap":2494631},{"date":"2023-11-03","current":-0.168292,"twenty":-6.435708,"median":-1.770571,"eighty":-0.418078,"marketCap":2289954},{"date":"2023-11-10","current":-0.14473,"twenty":-6.382656,"median":-1.762279,"eighty":-0.409718,"marketCap":1969335},{"date":"2023-11-17","current":-0.150928,"twenty":-6.32939,"median":-1.725918,"eighty":-0.404333,"marketCap":2053675},{"date":"2023-11-24","current":-0.182107,"twenty":-6.309338,"median":-1.723644,"eighty":-0.391583,"marketCap":2370483},{"date":"2023-12-01","current":-0.193716,"twenty":-6.233917,"median":-1.702773,"eighty":-0.383972,"marketCap":2521602},{"date":"2023-12-08","current":-0.1709,"twenty":-6.169245,"median":-1.692778,"eighty":-0.36252,"marketCap":2224608},{"date":"2023-12-15","current":-0.193103,"twenty":-6.069934,"median":-1.653044,"eighty":-0.34987,"marketCap":2513624},{"date":"2023-12-22","current":-0.202489,"twenty":-5.988525,"median":-1.639576,"eighty":-0.33386,"marketCap":2635795},{"date":"2023-12-29","current":-0.190949,"twenty":-5.965936,"median":-1.609201,"eighty":-0.326087,"marketCap":2485584},{"date":"2024-01-05","current":-0.175138,"twenty":-5.906942,"median":-1.603068,"eighty":-0.318867,"marketCap":2279767},{"date":"2024-01-12","current":-0.179655,"twenty":-5.835437,"median":-1.588762,"eighty":-0.309923,"marketCap":2338573},{"date":"2024-01-19","current":-0.156752,"twenty":-5.785202,"median":-1.57484,"eighty":-0.300896,"marketCap":2040439},{"date":"2024-01-26","current":-0.149608,"twenty":-5.73784,"median":-1.543955,"eighty":-0.283715,"marketCap":1947443},{"date":"2024-02-02","current":-0.202517,"twenty":-5.632387,"median":-1.521267,"eighty":-0.26618,"marketCap":2636169},{"date":"2024-02-09","current":-0.198673,"twenty":-5.516283,"median":-1.506326,"eighty":-0.246081,"marketCap":2586130},{"date":"2024-02-16","current":-0.183839,"twenty":-5.468749,"median":-1.485958,"eighty":-0.231177,"marketCap":2393038},{"date":"2024-02-23","current":-0.179226,"twenty":-5.435241,"median":-1.467652,"eighty":-0.22584,"marketCap":2332991},{"date":"2024-03-01","current":-0.183511,"twenty":-5.418095,"median":-1.458008,"eighty":-0.222814,"marketCap":2388759},{"date":"2024-03-08","current":-0.19158,"twenty":-5.388193,"median":-1.433652,"eighty":-0.217467,"marketCap":2493800},{"date":"2024-03-15","current":-0.181717,"twenty":-5.344181,"median":-1.426519,"eighty":-0.214048,"marketCap":2162612},{"date":"2024-03-22","current":-0.178134,"twenty":-5.276856,"median":-1.411242,"eighty":-0.210892,"marketCap":2119977},{"date":"2024-03-28","current":-0.162507,"twenty":-5.22679,"median":-1.402969,"eighty":-0.209044,"marketCap":1933993},{"date":"2024-04-05","current":-0.12824,"twenty":-5.176486,"median":-1.395966,"eighty":-0.207092,"marketCap":1526186},{"date":"2024-04-12","current":-0.059629,"twenty":-5.153068,"median":-1.382165,"eighty":-0.203508,"marketCap":709644},{"date":"2024-04-19","current":-0.039978,"twenty":-4.953916,"median":-1.353703,"eighty":-0.202112,"marketCap":475773},{"date":"2024-04-26","current":-0.037122,"twenty":-4.82601,"median":-1.344624,"eighty":-0.199814,"marketCap":441789},{"date":"2024-05-03","current":-0.03193,"twenty":-4.579583,"median":-1.327654,"eighty":-0.196543,"marketCap":380001},{"date":"2024-05-10","current":-0.019573,"twenty":-4.468851,"median":-1.315835,"eighty":-0.194843,"marketCap":232943},{"date":"2024-05-17","current":-0.016773,"twenty":-4.260951,"median":-1.299738,"eighty":-0.193471,"marketCap":207857},{"date":"2024-05-24","current":-0.014951,"twenty":-4.09331,"median":-1.289502,"eighty":-0.191328,"marketCap":185273},{"date":"2024-05-31","current":-0.875221,"twenty":-3.977221,"median":-1.280571,"eighty":-0.191328,"marketCap":10845737},{"date":"2024-06-07","current":-0.711827,"twenty":-3.916719,"median":-1.26296,"eighty":-0.191328,"marketCap":8820965},{"date":"2024-06-14","current":-0.646328,"twenty":-3.753136,"median":-1.259795,"eighty":-0.191328,"marketCap":8009295},{"date":"2024-06-21","current":-0.919879,"twenty":-3.739127,"median":-1.24753,"eighty":-0.191201,"marketCap":11399139},{"date":"2024-06-28","current":-0.439601,"twenty":-3.675149,"median":-1.239677,"eighty":-0.191201,"marketCap":5447534},{"date":"2024-07-05","current":-0.426593,"twenty":-3.653696,"median":-1.229824,"eighty":-0.191201,"marketCap":5286335},{"date":"2024-07-12","current":-0.404705,"twenty":-3.619858,"median":-1.222847,"eighty":-0.191201,"marketCap":5015109},{"date":"2024-07-19","current":-0.34689,"twenty":-3.574612,"median":-1.214641,"eighty":-0.191201,"marketCap":4298665},{"date":"2024-07-26","current":-0.460043,"twenty":-3.542352,"median":-1.20518,"eighty":-0.191201,"marketCap":5700848},{"date":"2024-08-02","current":-0.333262,"twenty":-3.519481,"median":-1.194237,"eighty":-0.191201,"marketCap":4129788},{"date":"2024-08-09","current":-0.538799,"twenty":-3.494471,"median":-1.173674,"eighty":-0.191201,"marketCap":6272162},{"date":"2024-08-16","current":-0.613066,"twenty":-3.480555,"median":-1.156813,"eighty":-0.191201,"marketCap":7136704},{"date":"2024-08-23","current":-0.665854,"twenty":-3.438864,"median":-1.144085,"eighty":-0.191201,"marketCap":7751206},{"date":"2024-08-30","current":-0.660757,"twenty":-3.376805,"median":-1.136349,"eighty":-0.191201,"marketCap":7691875},{"date":"2024-09-06","current":-0.602145,"twenty":-3.376805,"median":-1.110901,"eighty":-0.191201,"marketCap":7009565},{"date":"2024-09-13","current":-0.413807,"twenty":-3.376805,"median":-1.094407,"eighty":-0.191201,"marketCap":4817129},{"date":"2024-09-20","current":-0.268186,"twenty":-3.376805,"median":-1.082358,"eighty":-0.191201,"marketCap":3121952},{"date":"2024-09-27","current":-0.266972,"twenty":-3.376805,"median":-1.060599,"eighty":-0.191201,"marketCap":3107825},{"date":"2024-10-04","current":-0.213578,"twenty":-3.376805,"median":-1.030329,"eighty":-0.191201,"marketCap":2486260},{"date":"2024-10-11","current":-0.168678,"twenty":-3.376805,"median":-1.009988,"eighty":-0.190046,"marketCap":1963580},{"date":"2024-10-18","current":-0.209937,"twenty":-3.376805,"median":-0.99232,"eighty":-0.189565,"marketCap":2443881},{"date":"2024-10-25","current":-0.182027,"twenty":-3.376805,"median":-0.952495,"eighty":-0.187912,"marketCap":2118972},{"date":"2024-11-01","current":-0.167464,"twenty":-3.376805,"median":-0.919879,"eighty":-0.185058,"marketCap":1949454},{"date":"2024-11-08","current":-0.163824,"twenty":-3.376805,"median":-0.875221,"eighty":-0.183766,"marketCap":1907074},{"date":"2024-11-15","current":-0.31156,"twenty":-3.376805,"median":-0.856018,"eighty":-0.183278,"marketCap":5852334},{"date":"2024-11-22","current":-0.299758,"twenty":-3.376805,"median":-0.829699,"eighty":-0.183278,"marketCap":5630655},{"date":"2024-11-29","current":-0.259633,"twenty":-3.376805,"median":-0.828662,"eighty":-0.183278,"marketCap":4876945},{"date":"2024-12-06","current":-0.259633,"twenty":-3.376805,"median":-0.817084,"eighty":-0.183278,"marketCap":4876945},{"date":"2024-12-13","current":-0.240751,"twenty":-3.376805,"median":-0.779771,"eighty":-0.183278,"marketCap":4522258},{"date":"2024-12-20","current":-0.233693,"twenty":-3.376805,"median":-0.724757,"eighty":-0.183278,"marketCap":4389694},{"date":"2024-12-27","current":-0.254912,"twenty":-3.376805,"median":-0.696056,"eighty":-0.183278,"marketCap":4788273},{"date":"2025-01-03","current":-0.250192,"twenty":-3.376805,"median":-0.680226,"eighty":-0.183278,"marketCap":4699602},{"date":"2025-01-10","current":-0.245471,"twenty":-3.377546,"median":-0.662707,"eighty":-0.183259,"marketCap":4610930},{"date":"2025-01-17","current":-0.247831,"twenty":-3.377546,"median":-0.643462,"eighty":-0.183259,"marketCap":4655266},{"date":"2025-01-24","current":-0.321001,"twenty":-3.371306,"median":-0.632404,"eighty":-0.183259,"marketCap":6029678},{"date":"2025-01-31","current":-0.264354,"twenty":-3.349139,"median":-0.623547,"eighty":-0.183259,"marketCap":4965617},{"date":"2025-02-07","current":-0.257273,"twenty":-3.349139,"median":-0.613153,"eighty":-0.183259,"marketCap":4832609},{"date":"2025-02-14","current":-0.230861,"twenty":-3.349139,"median":-0.606861,"eighty":-0.183259,"marketCap":4336491},{"date":"2025-02-21","current":-0.225055,"twenty":-3.349139,"median":-0.603558,"eighty":-0.183259,"marketCap":4227425},{"date":"2025-02-28","current":-0.188517,"twenty":-3.327641,"median":-0.59756,"eighty":-0.183177,"marketCap":3541105},{"date":"2025-03-07","current":-0.250192,"twenty":-3.029241,"median":-0.573618,"eighty":-0.183161,"marketCap":4699602},{"date":"2025-03-14","current":-0.226258,"twenty":-2.806942,"median":-0.566727,"eighty":-0.183161,"marketCap":4250036},{"date":"2025-03-21","current":-0.23367,"twenty":-2.806942,"median":-0.54418,"eighty":-0.183161,"marketCap":4389251},{"date":"2025-03-28","current":-0.245471,"twenty":-2.806942,"median":-0.529698,"eighty":-0.183161,"marketCap":4610930},{"date":"2025-04-04","current":-0.549066,"twenty":-2.806942,"median":-0.529698,"eighty":-0.183161,"marketCap":13460358},{"date":"2025-04-11","current":-0.507492,"twenty":-2.792343,"median":-0.51662,"eighty":-0.183177,"marketCap":12441175},{"date":"2025-04-17","current":-0.652411,"twenty":-2.792343,"median":-0.515165,"eighty":-0.183177,"marketCap":15993852},{"date":"2025-04-25","current":-0.784281,"twenty":-2.806942,"median":-0.514103,"eighty":-0.183161,"marketCap":19226652},{"date":"2025-05-02","current":-0.7704,"twenty":-2.806942,"median":-0.514103,"eighty":-0.183161,"marketCap":18886358},{"date":"2025-05-09","current":-0.676532,"twenty":-2.806942,"median":-0.514103,"eighty":-0.183161,"marketCap":15833550},{"date":"2025-05-16","current":-0.670089,"twenty":-2.806942,"median":-0.514103,"eighty":-0.183161,"marketCap":15682754},{"date":"2025-05-23","current":-0.686197,"twenty":-2.806942,"median":-0.514103,"eighty":-0.183161,"marketCap":16059744},{"date":"2025-05-30","current":-0.574472,"twenty":-2.806942,"median":-0.514103,"eighty":-0.183161,"marketCap":13444946},{"date":"2025-06-06","current":-0.515066,"twenty":-2.806942,"median":-0.514103,"eighty":-0.183161,"marketCap":12054609},{"date":"2025-06-13","current":-0.538777,"twenty":-2.806942,"median":-0.514103,"eighty":-0.183161,"marketCap":12609538},{"date":"2025-06-20","current":-0.561521,"twenty":-2.809596,"median":-0.513091,"eighty":-0.182989,"marketCap":13141846},{"date":"2025-06-27","current":-0.63085,"twenty":-2.809596,"median":-0.513091,"eighty":-0.182989,"marketCap":14764408},{"date":"2025-07-03","current":-0.650759,"twenty":-2.809596,"median":-0.513091,"eighty":-0.182989,"marketCap":15230367},{"date":"2025-07-11","current":-0.695861,"twenty":-2.809596,"median":-0.513091,"eighty":-0.182989,"marketCap":16285937},{"date":"2025-07-18","current":-0.644316,"twenty":-2.809596,"median":-0.513091,"eighty":-0.182989,"marketCap":15079572},{"date":"2025-07-25","current":-0.657202,"twenty":-2.809596,"median":-0.513091,"eighty":-0.182989,"marketCap":15381163},{"date":"2025-08-01","current":-0.670089,"twenty":-2.809596,"median":-0.513091,"eighty":-0.182989,"marketCap":15682754},{"date":"2025-08-08","current":-0.635553,"twenty":-2.809596,"median":-0.513091,"eighty":-0.182989,"marketCap":14874489},{"date":"2025-08-15","current":-0.631301,"twenty":-2.809596,"median":-0.513091,"eighty":-0.182989,"marketCap":14774964},{"date":"2025-08-22","current":-0.466094,"twenty":-2.809596,"median":-0.511092,"eighty":-0.182989,"marketCap":11230525},{"date":"2025-08-29","current":-0.795382,"twenty":-2.809596,"median":-0.509023,"eighty":-0.182989,"marketCap":19164720},{"date":"2025-09-05","current":-0.91734,"twenty":-2.812251,"median":-0.508583,"eighty":-0.182817,"marketCap":22103310},{"date":"2025-09-12","current":-0.986273,"twenty":-2.809596,"median":-0.509023,"eighty":-0.182989,"marketCap":23764252},{"date":"2025-09-19","current":-0.837802,"twenty":-2.809596,"median":-0.509023,"eighty":-0.182989,"marketCap":20186838},{"date":"2025-09-26","current":-0.816592,"twenty":-2.809596,"median":-0.509023,"eighty":-0.182989,"marketCap":19675779},{"date":"2025-10-03","current":-0.859012,"twenty":-2.809596,"median":-0.509023,"eighty":-0.182989,"marketCap":20697897},{"date":"2025-10-10","current":-1.0609,"twenty":-2.809596,"median":-0.509023,"eighty":-0.182989,"marketCap":25562380},{"date":"2025-10-17","current":-0.871023,"twenty":-2.809596,"median":-0.509023,"eighty":-0.182989,"marketCap":20987295},{"date":"2025-10-24","current":-0.83787,"twenty":-2.809596,"median":-0.509023,"eighty":-0.182989,"marketCap":20188471},{"date":"2025-10-31","current":-0.843898,"twenty":-2.809596,"median":-0.509023,"eighty":-0.182989,"marketCap":20333712},{"date":"2025-11-07","current":-0.66909,"twenty":-2.809596,"median":-0.509023,"eighty":-0.182989,"marketCap":16121728},{"date":"2025-11-14","current":-0.717313,"twenty":-2.809596,"median":-0.509023,"eighty":-0.182989,"marketCap":17283655},{"date":"2025-11-21","current":-0.941679,"twenty":-2.809596,"median":-0.509023,"eighty":-0.182989,"marketCap":14418054},{"date":"2025-11-28","current":-1.261644,"twenty":-2.809596,"median":-0.509023,"eighty":-0.182989,"marketCap":19317026},{"date":"2025-12-05","current":-1.197948,"twenty":-2.809596,"median":-0.509023,"eighty":-0.182989,"marketCap":18341787},{"date":"2025-12-12","current":-1.187621,"twenty":-2.809596,"median":-0.509023,"eighty":-0.182989,"marketCap":18183668},{"date":"2025-12-19","current":-1.057877,"twenty":-2.809596,"median":-0.509023,"eighty":-0.182989,"marketCap":16197149},{"date":"2025-12-26","current":-1.083678,"twenty":-2.809596,"median":-0.509023,"eighty":-0.182989,"marketCap":16592201},{"date":"2026-01-02","current":-1.114641,"twenty":-2.809596,"median":-0.509023,"eighty":-0.182989,"marketCap":17066264},{"date":"2026-01-09","current":-1.349609,"twenty":-2.809596,"median":-0.509023,"eighty":-0.182989,"marketCap":20663870},{"date":"2026-01-16","current":-1.338268,"twenty":-2.809596,"median":-0.509023,"eighty":-0.182989,"marketCap":20490224},{"date":"2026-01-23","current":-1.406316,"twenty":-2.809596,"median":-0.509023,"eighty":-0.182989,"marketCap":21532100},{"date":"2026-01-30","current":-1.185161,"twenty":-2.809596,"median":-0.509023,"eighty":-0.182989,"marketCap":18146003},{"date":"2026-02-05","current":-0.884764,"twenty":-2.809596,"median":-0.509023,"eighty":-0.182989,"marketCap":13546617}],"updateTime":1770430076766},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALLR\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2608987871","title":"Allarity announce enrollment open for Phase 2 trial of stenoparib, temozolomide","url":"https://stock-news.laohu8.com/highlight/detail?id=2608987871","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608987871?lang=en_us&edition=fundamental","pubTime":"2026-02-03 21:20","pubTimestamp":1770124833,"startTime":"0","endTime":"0","summary":"Allarity (ALLR) Therapeutics announced that enrollment is now open for its new Phase 2 clinical trial evaluating the combination of stenoparib and ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/allarity-announce-enrollment-open-for-phase-2-trial-of-stenoparib-temozolomide-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/allarity-announce-enrollment-open-for-phase-2-trial-of-stenoparib-temozolomide-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ALLR"],"gpt_icon":0},{"id":"2608879859","title":"Allarity Therapeutics Announces That Its Collaborative Phase 2 Trial With the United States Veteran’s Administration Combining Stenoparib With Temozolomide in Relapsed Small Cell Lung Cancer Is NOW Open for Enrollment","url":"https://stock-news.laohu8.com/highlight/detail?id=2608879859","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608879859?lang=en_us&edition=fundamental","pubTime":"2026-02-03 21:00","pubTimestamp":1770123652,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nFWN3YZ02Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ALLR"],"gpt_icon":0},{"id":"2608005876","title":"Allarity Therapeutics Partners with U.S. Department of Veterans Affairs for Phase 2 Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2608005876","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608005876?lang=en_us&edition=fundamental","pubTime":"2026-02-03 21:00","pubTimestamp":1770123629,"startTime":"0","endTime":"0","summary":"Allarity Therapeutics Inc. has entered into a collaboration with the U.S. Department of Veterans Affairs  to conduct a Phase 2 clinical trial evaluating the combination of stenoparib and temozolomide for the treatment of recurrent small cell lung cancer . The trial, fully funded by the VA's Special Emphasis Panel on Precision Oncology, is now open for enrollment at 11 VA sites across the United States. This partnership aims to explore the potential benefits and improved safety profile of stenoparib in combination regimens for patients with relapsed SCLC, particularly among veterans who have limited treatment options.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Allarity Therapeutics Inc. published the original content used to generat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nNDL67nJML:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU2095319765.USD","SG9999014013.SGD","LU2210149790.SGD","IE00BKPKM429.USD","LU0314104364.USD","IE00B3QW5Z07.USD","BK4112","SG9999014005.SGD","SG9999014039.USD","LU2210150020.SGD","BK4585","IE00BGHQF748.EUR","ALLR","SG9999014021.USD","NDAQ","IE00B64PRP62.GBP","BK4588"],"gpt_icon":0},{"id":"2607822790","title":"Allarity Therapeutics Inc - on Jan 28, Co Entered Stock Purchase Agreement With Tumim Stone Capital - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2607822790","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607822790?lang=en_us&edition=fundamental","pubTime":"2026-01-29 20:50","pubTimestamp":1769691044,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nFWN3YU15O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALLR","BK4139"],"gpt_icon":0},{"id":"2607222082","title":"Allarity Therapeutics Inc - Company May Sell up to $6 Mln in Newly Issued Shares - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2607222082","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607222082?lang=en_us&edition=fundamental","pubTime":"2026-01-29 20:50","pubTimestamp":1769691044,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nFWN3YU15O:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALLR","BK4139"],"gpt_icon":0},{"id":"2595977115","title":"Allarity Therapeutics Advances Stenoparib Toward FDA Approval After Strategic Realignment","url":"https://stock-news.laohu8.com/highlight/detail?id=2595977115","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595977115?lang=en_us&edition=fundamental","pubTime":"2025-12-31 21:00","pubTimestamp":1767186016,"startTime":"0","endTime":"0","summary":"Allarity Therapeutics Inc. issued a business update in a letter to shareholders from CEO Thomas H. Jensen. The company reported significant progress in 2025, highlighting the advancement of its lead asset, stenoparib—a dual PARP and WNT pathway inhibitor—toward FDA approval for advanced ovarian cancer. Allarity also broadened the potential indications for stenoparib, including its application in recurrent small cell lung cancer and other difficult-to-treat cancers. The company emphasized strengthened financial foundations and continued clinical development. Looking ahead to 2026, Allarity plans to accelerate stenoparib’s path to approval, expand its indications, and explore additional growth opportunities.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment,","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251231:nNDL1d427w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","SG9999014013.SGD","LU0314104364.USD","IE00B3QW5Z07.USD","LU2095319765.USD","SG9999014005.SGD","BK4588","IE00B64PRP62.GBP","LU2210150020.SGD","LU2210149790.SGD","SG9999014021.USD","IE00BGHQF748.EUR","NDAQ","ALLR","BK4139","IE00BKPKM429.USD","BK4585","BK4112"],"gpt_icon":0},{"id":"2593608415","title":"Allarity Therapeutics Raises $2.5 Million in Private Placement of Unregistered Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2593608415","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593608415?lang=en_us&edition=fundamental","pubTime":"2025-12-23 22:22","pubTimestamp":1766499739,"startTime":"0","endTime":"0","summary":"Allarity Therapeutics Inc. has announced the completion of an additional closing of a private placement with an accredited investor, selling 255,103 shares of common stock at $0.98 per share, raising approximately $250,000 in gross proceeds. This transaction is part of a previously disclosed Securities Purchase Agreement, under which the company had earlier sold 1,562,500 shares and/or pre-funded warrants for gross proceeds of about $2.5 million. The shares were sold in an unregistered offering, relying on an exemption from registration under Section 4 of the Securities Act. Allarity Therapeutics intends to use the net proceeds for general corporate purposes and working capital.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Allarity T","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nNDL3hBXP4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALLR"],"gpt_icon":0},{"id":"2589098356","title":"Allarity Therapeutics Sets New CFO Compensation Package With $367,700 Salary and $160,000 RSUs","url":"https://stock-news.laohu8.com/highlight/detail?id=2589098356","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589098356?lang=en_us&edition=fundamental","pubTime":"2025-12-08 22:17","pubTimestamp":1765203445,"startTime":"0","endTime":"0","summary":"Allarity Therapeutics Inc. has entered into a new employment agreement with Chief Financial Officer Jeffrey S. Ervin, effective December 3, 2025. Under the agreement, Ervin will serve as CFO on a full-time basis with an annual base salary of $367,700. He will also receive restricted stock units valued at $160,000, subject to time-based vesting, and is eligible for an annual performance bonus of up to 30% of his base salary, contingent on individual and corporate objectives. If his employment is terminated without cause, for good reason, or in connection with a change of control, Ervin will receive six months of his final base salary as severance, paid as salary continuation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Allarity Thera","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nNDL3vHHn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALLR"],"gpt_icon":0},{"id":"2588044174","title":"BRIEF-Allarity Therapeutics Inc - To Offer Up To $50 Million In Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2588044174","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588044174?lang=en_us&edition=fundamental","pubTime":"2025-12-03 22:12","pubTimestamp":1764771161,"startTime":"0","endTime":"0","summary":"BRIEF-Allarity Therapeutics Inc - To Offer Up To $50 Million In Securities Dec 3  - Allarity Therapeutics Inc ALLR.O:ALLARITY THERAPEUTICS INC - TO OFFER UP TO $50 MILLION IN SECURITIES - SEC FILINGSource text: [ID:n0001213900-25-117592]Further company coverage: ALLR.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nFWN3X90FG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALLR"],"gpt_icon":0},{"id":"2588044126","title":"Allarity Therapeutics Inc - to Offer up to $50 Mln in Securities - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2588044126","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588044126?lang=en_us&edition=fundamental","pubTime":"2025-12-03 22:12","pubTimestamp":1764771137,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nFWN3X90FG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALLR","BK4139"],"gpt_icon":0},{"id":"2583501092","title":"Allarity Therapeutics's Q3 net loss narrows","url":"https://stock-news.laohu8.com/highlight/detail?id=2583501092","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583501092?lang=en_us&edition=fundamental","pubTime":"2025-11-14 22:08","pubTimestamp":1763129319,"startTime":"0","endTime":"0","summary":"Allarity Therapeutics's Q3 net loss narrowsOverviewAllarity receives FDA Fast Track designation for stenoparib in advanced ovarian cancerCompany reports median overall survival exceeding 25 months in ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nL1N3WQ0LT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALLR","BK4139"],"gpt_icon":0},{"id":"2583501290","title":"Allarity Therapeutics reports third quarter net loss of $2.8 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2583501290","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583501290?lang=en_us&edition=fundamental","pubTime":"2025-11-14 22:00","pubTimestamp":1763128814,"startTime":"0","endTime":"0","summary":"Allarity Therapeutics Inc. reported a cash position of $16.9 million as of September 30, 2025, a decrease of $0.9 million from June 30, 2025. Research and development expenses for the third quarter of 2025 were $1.2 million, up from $1.0 million in the same period in 2024. General and administrative expenses were $1.3 million, down from $1.6 million in the third quarter of 2024. The net loss attributable to common stockholders was $2.8 million, compared to a net loss of $12.2 million in the third quarter of 2024. Key business developments included receiving FDA Fast Track designation for stenoparib in advanced ovarian cancer, reporting median overall survival now exceeding 25 months in an ongoing Phase 2 trial, and signing a new commercial agreement to license breast cancer DRP algorithms and laboratory services. The company maintains a financial runway through the fourth quarter of 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nNDL2jxvym:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","LU2210149790.SGD","BK4139","BK4588","BK4112","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","BK4585","NDAQ","LU2210150020.SGD","LU2095319765.USD","IE00B64PRP62.GBP","IE00BKPKM429.USD","ALLR"],"gpt_icon":0},{"id":"2583012885","title":"Allarity Therapeutics Q3 Operating Expenses USD 2.518 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2583012885","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583012885?lang=en_us&edition=fundamental","pubTime":"2025-11-14 22:00","pubTimestamp":1763128803,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nPLX11943B:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALLR","BK4139"],"gpt_icon":0},{"id":"2583233501","title":"Allarity Therapeutics Provides Third Quarter 2025 Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2583233501","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583233501?lang=en_us&edition=fundamental","pubTime":"2025-11-14 22:00","pubTimestamp":1763128802,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nTUA1Z0LN9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ALLR"],"gpt_icon":0},{"id":"2570074698","title":"U.S. RESEARCH ROUNDUP-Carmax, Mirion Technologies, Valmont Industries","url":"https://stock-news.laohu8.com/highlight/detail?id=2570074698","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570074698?lang=en_us&edition=fundamental","pubTime":"2025-09-26 14:53","pubTimestamp":1758869609,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Carmax, Mirion Technologies, Valmont IndustriesSept 26 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.listed companies, includ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250926:nL5N3VD07G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2125909916.SGD","FRME","LU1116320901.HKD","BK4023","LU0238689110.USD","LU0823434583.USD","THO","CALM","LU2168563687.JPY","LU2125154935.USD","VMI","IE00BLDYK493.USD","LU2210149790.SGD","IMRX","LU2211817866.USD","LU0980610538.SGD","LU2168564065.EUR","LU0265550946.USD","MCK","LU0097036916.USD","MIR","LU1551013425.SGD","GH","FHN","LEVI","LU2089279066.USD","KMX","BK4551","LU1061106388.HKD","LU0130102774.USD","CRNX","LU0965509010.AUD","ALLR","BK4007","LU1035775433.USD","LU1116320737.USD","LU2324357040.USD","SNX","ROL","LU0648001328.SGD","LU1983260115.SGD","LU0234572021.USD","KVYO","LU0053671581.USD"],"gpt_icon":1},{"id":"2570075969","title":"Allarity Therapeutics Inc : Ascendiant Capital Markets Raises Target Price to $9.25 From $9","url":"https://stock-news.laohu8.com/highlight/detail?id=2570075969","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570075969?lang=en_us&edition=fundamental","pubTime":"2025-09-26 13:09","pubTimestamp":1758863360,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250926:nFWN3VD09F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ALLR"],"gpt_icon":0},{"id":"2570051044","title":"Allarity files to sell 1.56M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2570051044","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570051044?lang=en_us&edition=fundamental","pubTime":"2025-09-26 05:25","pubTimestamp":1758835529,"startTime":"0","endTime":"0","summary":"17:21 EDT Allarity (ALLR) files to sell 1.56M shares of common stock for holders Published first on TheFly – the ultimate source for real-time, mar...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/allarity-files-to-sell-1-56m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/allarity-files-to-sell-1-56m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ALLR"],"gpt_icon":0},{"id":"2569067967","title":"Allarity Therapeutics Announces Landmark Phase 2 Results: Stenoparib Surpasses 25-Month Median Overall Survival in Advanced Ovarian Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2569067967","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569067967?lang=en_us&edition=fundamental","pubTime":"2025-09-24 19:59","pubTimestamp":1758715179,"startTime":"0","endTime":"0","summary":"Allarity Therapeutics Announces Landmark Phase 2 Results: Stenoparib Surpasses 25-Month Median Overall Survival in Advanced Ovarian Cancer Trial. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Allarity Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 24, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250924:nNDL2bwL1K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALLR"],"gpt_icon":0},{"id":"2569719002","title":"Allarity Therapeutics CEO to Present at Biomarkers & Precision Medicine 2025 Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2569719002","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569719002?lang=en_us&edition=fundamental","pubTime":"2025-09-23 23:16","pubTimestamp":1758640566,"startTime":"0","endTime":"0","summary":"Allarity Therapeutics, Inc., a Phase 2 clinical-stage pharmaceutical company, will be attending the Biomarkers & Precision Medicine 2025 conference in London. The company's CEO, Thomas Jensen, is set to present on October 1, 2025, at 4:00 PM. His presentation, titled \"A Gene Expression Based Biomarker For Predicting Response To Treatment With Stenoparib,\" will focus on Allarity's research and its innovative DRP companion diagnostic platform.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Allarity Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 22, 2025, and is ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250923:nNDLbZsJYb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALLR","BK4139"],"gpt_icon":0},{"id":"2569735784","title":"Allarity presents new Phase 2 clinical data for Stenoparib","url":"https://stock-news.laohu8.com/highlight/detail?id=2569735784","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569735784?lang=en_us&edition=fundamental","pubTime":"2025-09-22 20:20","pubTimestamp":1758543654,"startTime":"0","endTime":"0","summary":"Allarity (ALLR) Therapeutics, a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib, a differentiated, dual PARP and W...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/allarity-presents-new-phase-2-clinical-data-for-stenoparib-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/allarity-presents-new-phase-2-clinical-data-for-stenoparib-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ALLR"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":35,"code":"91000000","status":"200"}]}}